Sabarubicin

DB12410InvestigationalSmall molecule

Sabarubicin has been used in trials studying the treatment of Prostate Cancer, Testicular Germ Cell Tumor, and Unspecified Adult Solid Tumor, Protocol Specific.

Chemical structure of Sabarubicin
Formula / weight
C32H37NO13 · 643.6351 g/mol (avg)
Code names
MEN-10755

Resolves to

Compound
UNIIXS499WOZ93CAS211100-13-9ChEMBLCHEMBL1230227PubChem151897
Structure
InChIKeyVQHRZZISQVWPLK-UIRGBLDSSA-NSMILES[H][C@]1(N)C[C@]([H])(O[C@]2([H])[C@]([H])(C)O[C@]([H])(C[C@]2([H])O)O[C@@]2([H])C[C@@](O)(CC3=C(O)C4=C(C(O)=C23)C(=O)C2=CC=CC=C2C4=O)C(=O)CO)O[C@@]([H])(C)[C@@]1([H])O
Targets
Q02880TOP2BP11388TOP2A

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Sabarubicin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In